Ind Swift Limited is an India-based company, which is engaged in manufacturing and trading of pharmaceutical and healthcare products. The Company's divisions include Nova Division, Ethical Division, Generic Division, and Ayurveda Division. The Nova Division is a multispecialty division. Its portfolio covers all the therapeutic segments which are available in all the other divisions like respiratory inclusive of ENT, dentistry, anti-infective, cardio-diabetic and orthopedic therapies. The Nova Division Products include Aclovin, Aclovin - SR, Adelive oil and Agipod D/S. The Ethical Division is focused on gynecology, pediatrics, dermatology and GP and its ambit extends to a wide range of medicines. The Generic Division is divided into various therapeutic segments, namely antibiotic, anti-cold, nutraceuticals, anti-diarrhoeal, anti-malarial and anti-depressants. The Ayurveda Division's products include Swift Hangover Capsules, Oliade Oil, Swift Tulsi Drops and Majitrich Capsules.

Employees

1,054

Sector

More about the company

08/08/25	Ind-Swift Laboratories Limited Completed the acquisition of Ind-Swift Limited.	CI
22/07/25	Ind-Swift Limited Announces Resignation of Cs Puneet Khurana as Company Secretary & Compliance Officer and A Key Managerial Personnel, Effective from July 22, 2025	CI
17/07/25	Ind Swift says NCLT approves amalgamation of Ind-Swift Limited with Ind-Swift Laboratories	RE
25/06/25	Ind-Swift Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2025	CI
30/05/25	Ind-Swift Gets Renewed Approval from UK Drug Regulator for Punjab, India Unit	MT
08/04/25	Ind-Swift Completes Sale of Industrial Land in Himachal Pradesh, India	MT
20/02/25	Ind-Swift Laboratories Names Chief Operating Officer	MT
20/02/25	Ind-Swift Limited Appoints Anil Agrawal as Chief Operating Officer	CI
11/02/25	Ind-Swift Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	CI
06/02/25	Ind-Swift Limited Receives Order from the Office of Assistant Commissioner of State Tax, Ludhiana	CI
14/11/24	Ind-Swift Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024	CI
14/11/24	Ind-Swift Limited Appoints Mr. Puneet Khurana as the Company Secretary and Compliance Officer	CI
02/10/24	Ind-Swift Laboratories to Acquire Land in Punjab, India for New Formulations Facility	MT

30/07/22	Whether The Use Of The Word ‘Arbitration' In The Heading Of An Agreement Entails The Existence Of An Arbitration Agreement? The Delhi High Court Answers	AQ
26/03/22	Ind Swift : Demise	PU

IND-SWIFT Stock

Stocks

INDSWFTLTD

INE788B01028

Chart: IND-SWIFT

Latest news : IND-SWIFT

Press Releases: IND-SWIFT

News in other languages: IND-SWIFT

Quotes and Performance

Managers and Directors: IND-SWIFT

Company Profile